References
- HerfarthHHMethotrexate for Inflammatory Bowel Diseases - New DevelopmentsDig Dis2016341–214014626981630
- WeinblattMEMethotrexate in rheumatoid arthritis: a quarter century of developmentTrans Am Clin Climatol Assoc2013124162523874006
- HowardSCMccormickJPuiCHBuddingtonRKHarveyRDPreventing and Managing Toxicities of High-Dose MethotrexateOncologist201621121471148227496039
- StollerRGHandeKRJacobsSARosenbergSAChabnerBAUse of plasma pharmacokinetics to predict and prevent methotrexate toxicityN Engl J Med197729712630634302412
- MitchellMSWawroNWDecontiRCKaplanSRPapacRBertinoJREffectiveness of high-dose infusions of methotrexate followed by leucovorin in carcinoma of the head and neckCancer Res1968286108810944298056
- AbreyLEDeangelisLMYahalomJLong-term survival in primary CNS lymphomaJ Clin Oncol19981638598639508166
- MoePJHolenAHigh-dose methotrexate in childhood allPediatr Hematol Oncol200017861562211127393
- CooperSLBrownPATreatment of pediatric acute lymphoblastic leukemiaPediatr Clin North Am2015621617325435112
- PuiCHRellingMVEvansWEIs mega dose of methotrexate beneficial to patients with acute lymphoblastic leukemia?Leuk Lymphoma200647122431243217169783
- PDQ® Pediatric Treatment Editorial Board Childhood Non-Hodgkin Lymphoma Treatment (PDQ(R)): Health Professional Version PDQ Cancer Information SummariesBethesda, MDNational Cancer Institute2002
- WoessmannWSeidemannKMannGThe impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95Blood2005105394895815486066
- ChoeyprasertWPakakasamaSSirachainanNComparative outcome of Thai pediatric osteosarcoma treated with two protocols: the role of high-dose methotrexate (HDMTX) in a single institute experienceAsian Pac J Cancer Prev201415229823982925520112
- IsakoffMSBielackSSMeltzerPGorlickROsteosarcoma: Current Treatment and a Collaborative Pathway to SuccessJ Clin Oncol201533273029303526304877
- Patiño-GarcíaAZalacaínMMarrodánLSan-JuliánMSierrasesúmagaLMethotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expressionJ Pediatr2009154568869319159907
- HolmboeLAndersenAMMørkridLSlørdalLHallKSHigh dose methotrexate chemotherapy: pharmacokinetics, folate and toxicity in osteosarcoma patientsBr J Clin Pharmacol201273110611421707700
- FleisherMAntifolate analogs: mechanism of action, analytical methodology, and clinical efficacyTher Drug Monit19931565215268122287
- GoodsellDSThe molecular perspective: methotrexateStem Cells199917531431510527466
- RajagopalanPTZhangZMccourtLDwyerMBenkovicSJHammesGGInteraction of dihydrofolate reductase with methotrexate: ensemble and single-molecule kineticsProc Natl Acad Sci U S A20029921134811348612359872
- Longo-SorbelloGSBertinoJRCurrent understanding of methotrexate pharmacology and efficacy in acute leukemias. Use of newer antifolates in clinical trialsHaematologica200186212112711224479
- KhanZATripathiRMishraBMethotrexate: a detailed review on drug delivery and clinical aspectsExpert Opin Drug Deliv20129215116922251428
- BhojwaniDSabinNDPeiDMethotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemiaJ Clin Oncol201432994995924550419
- FerrariSOrlandiMAvellaMEffects of hydration on plasma concentrations of methotrexate in patients with osteosarcoma treated with high doses of methotrexateMinerva Med19928352892931589134
- KarremannMSauerbierJMeierCThe impact of prehydration on the clearance and toxicity of high-dose methotrexate for pediatric patientsLeuk Lymphoma201455122874287824576168
- MikkelsenTSMamoudouADTuckuvieneRWehnerPSSchroederHExtended duration of prehydration does not prevent nephrotoxicity or delayed drug elimination in high-dose methotrexate infusions: a prospectively randomized cross-over studyPediatr Blood Cancer201461229730124039194
- KinoshitaAKurosawaYKondohKEffects of sodium in hydration solution on plasma methotrexate concentrations following high-dose methotrexate in children with acute lymphoblastic leukemiaCancer Chemother Pharmacol200351325626012655445
- TreonSPChabnerBAConcepts in use of high-dose methotrexate therapyClin Chem1996428 Pt 2132213298697606